COMMUNIQUÉS West-GlobeNewswire

Symphony Health’s New Enhanced Views Program Expands Evidence-Driven Insights

03/04/2018 - 15:00

Enhanced panel provides expanded insights across multiple information assets and offers new insight to patient activity and the treatment journey CONSHOHOCKEN, Pa., April 03, 2018 (GLOBE NEWSWIRE) -- Symphony Health , a [...]

Adamas Announces First Patient Enrolled in Phase 3 Trial of ADS-5102 in Multiple Sclerosis Patients with Walking Impairment

03/04/2018 - 15:00

EMERYVILLE, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the first patient has been enrolled in its pivotal Phase 3 clinical trial of ADS-5102 (amantadine [...]

WellDoc Announces Providence Health & Services’ Implementation of BlueStar® Digital Therapeutic in a Pilot Program for Individuals with Type 2 Diabetes

03/04/2018 - 15:00

COLUMBIA, Md., April 03, 2018 (GLOBE NEWSWIRE) -- Today, WellDoc ® announced a pilot program in the Providence Health & Services Oregon/SW Washington Region to examine the use of WellDoc’s BlueStar ® , an FDA- [...]

AXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South Korea

03/04/2018 - 15:00

NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (AXIM ® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that it has entered into a Memo of [...]

Ceapro Announces Acceptance of Abstract for Presentation at the Nutrition 2018 Meeting

03/04/2018 - 15:00

EDMONTON, Alberta, April 03, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO ) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients [...]

NewLink Genetics Announces Participation at The H.C. Wainwright Annual Global Life Sciences Conference

03/04/2018 - 15:00

AMES, Iowa, April 03, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) announced today it will present at the H. C. Wainwright Annual Global Life Sciences Conference. The conference is being held on [...]

ProLynx extends lead in half-life extension platform technology – Shows primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system

03/04/2018 - 15:00

SAN FRANCISCO, April 03, 2018 (GLOBE NEWSWIRE) -- ProLynx announced today the publication of a paper demonstrating its leading capabilities to exploit primary deuterium kinetic isotope effects (1°DKIEs) for prolonging [...]

Q-Centrix Solution Among First to Be Certified for CathPCI v5 Reporting

03/04/2018 - 15:00

With the new certification, Q-Centrix continues to lead the way in providing comprehensive solutions for participation in major cardiac-care registries Chicago, April 03, 2018 (GLOBE NEWSWIRE) -- Q-Centrix adds [...]

Wildflower Secures $720,000 Purchase Order

03/04/2018 - 15:00

VANCOUVER, British Columbia, April 03, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (FWB:RSP) (“Wildflower” or the "Company") has received its first purchase order pursuant to the recently announced [...]

CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year

03/04/2018 - 14:57

OXNARD, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery company, today reported the company’s Q1 2018 accomplishments. The company strengthened its leadership team [...]

UroGen Pharma Announces Presentation of Results from Interim Analysis of Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel™) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)

03/04/2018 - 14:32

RA’ANANA, Israel and NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]

Terveystalo Plc: Lääkäriasema ILO to become a part of Terveystalo

03/04/2018 - 14:30

Terveystalo has acquired Lääkäriasema ILO (Juha Uusimäki Oy) on 29 March 2018. The company operates clinics in Tuuri and Vimpeli. The company's personnel will be transferred to Terveystalo as old employees and [...]

Cesca Therapeutics Inc. Announces Release of X-Mini™ Cell Selection Kit for the CAR-T Research Market

03/04/2018 - 14:30

RANCHO CORDOVA, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]

ChemoCentryx to Present at Two Upcoming Investor Conferences

03/04/2018 - 14:30

MOUNTAIN VIEW, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor [...]

Bellerophon Therapeutics to Provide Corporate Update at H.C. Wainwright Annual Global Life Sciences Conference

03/04/2018 - 14:30

WARREN, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that Fabian Tenenbaum, [...]

BriaCell’s Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal

03/04/2018 - 14:30

BERKELEY, Calif. and VANCOUVER, British Columbia, April 03, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]

First Choice Healthcare Solutions Reports 2017 Results and Update on Strategic Partnership with Steward Health Care

03/04/2018 - 14:30

MELBOURNE, Fla., April 03, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB:FCHS) ("First Choice" or the "Company"), a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]

Status regarding Novo Nordisk's holding of its own shares (31 March 2018)

03/04/2018 - 14:15

Bagsværd, Denmark, 3 April 2018 - In continuation of the company's announcements dated 1 November 2017 and 5 February 2018 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York [...]

Treos Bio Names Gábor Illés as Its Chief Financial Officer

03/04/2018 - 14:15

SAN FRANCISCO and LONDON, April 03, 2018 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, off-the-shelf precision cancer vaccines coupled with companion diagnostics, today [...]